Real-world Comparative Study of Androgen Receptor Signaling Inhibitors in Japanese Patients With Non-metastatic Castration-resistant Prostate Cancer
In Japanese real-world practice, ARSI effectiveness in nmCRPC appears influenced by treatment persistence, timing of initiation, and treatment sequencing. Early initiation and careful management of adverse events may optimize outcomes, whereas sequential ARSI use shows limited benefit.
Authors
- Seiji Shimada
- Takao Mishima (ORCID: https://orcid.org/0000-0002-0825-0878)
- HIDEFUMI KINOSHITA
- MASAAKI YANISHI
Institutions
- Kansai Medical University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2026-03-27
- DOI
- https://doi.org/10.21873/anticanres.18103
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00